IBIO iBio Inc Net earnings per share growth forecast for next year
FastPharming technology accelerates the release of biologics, supporting upward momentum, and the trend in expected earnings per share confirms this trajectory. The value of -72.30 describes the current forecast level. Patents in AI cancer therapy, which remain independent of macroeconomic factors, provide stability. iBio, Inc. (IBIO) solidifies its positive market status through its high authority as an innovator in antibody discovery.
Comprehensive metric breakdowns and analytics for ibioinc.com (IBIO)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
IBIO - Net Financial Result|Expected Profit iBio, Inc.|IBIO - Price to Earnings Multiple|Forward P/E Multiple iBio, Inc.|IBIO - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio iBio|IBIO - Operating income before deduction of amortization|Net earnings per share (EPS TTM) iBio|IBIO - Net earnings per share for the last four quarters|Quarterly EPS earnings growth ibioinc.com|IBIO - Earnings per share growth in current year|Earnings growth forecast for next year iBio, Inc.
- total revenue and sales volume data:
Initial company analysis:IBIO, iBio Corp
iBio, Inc. (IBIO) developments in AI-driven antibodies for cancer therapy make the consensus EPS forecast for the coming year a key indicator of technology commercialization. This metric measures the expected percentage growth in earnings per share, reflecting market confidence in the scalability of the business model. Analyzing the dynamics of this indicator allows for the determination of fair asset value and helps avoid overpaying for securities during peaks of optimism.
Competitors of iBio, Inc.
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Grifols Biemat GRFS|ADPT: Earnings growth forecast for next year|CLDX (celldex.com) - Net earnings per share growth forecast for next year|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|BioCryst Pharmaceuticals, Inc. (BCRX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Vera Pharma (VERA)|DNTH - Expected net earnings per share growth next year|Pharvaris N.V. - Expected earnings per share growth for next year|Expected earnings per share trend next year ABCL|Tourmaline Bio - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Precigen Inc PGEN|Pharming (PHAR) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year NKTR|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|Expected earnings per share growth for next year zenasbio.com (ZBIO)|Expected earnings per share growth for next year IMNM (Immunome)|Consensus forecast of earnings per share growth for next year Gossamer Bio Inc|Earnings growth forecast for next year KALV (KalVista Pharmaceuticals Inc)|Consensus forecast of earnings per share growth for next year Septerna Pharma (SEPN)|Pieris Pharmaceuticals - Earnings growth forecast for next year|SVRA: Net earnings per share growth forecast for next year|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Expected net earnings per share growth next year enGene Corp ENGN|Net earnings per share growth forecast for next year RAPT Therapeutics, Inc. (RAPT)|JBIO: Net earnings per share change forecast for next year|Earnings growth forecast for next year ACRS (Aclaris Therapeutics, Inc.)|Expected earnings per share trend next year KYTX|Tiziana Life Sciences PLC - Earnings growth forecast for next year|CABA - Earnings growth forecast for next year|Ventyx Biosciences (VTYX) - Net earnings per share growth forecast for next year|theratech.com - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Avalo Therapeutics|Expected earnings per share growth for next year Eledon Pharmaceuticals Inc. (ELDN)|Earnings growth forecast for next year AGEN|Earnings growth forecast for next year Climb Bio, Inc (CLYM)|Zura Bio Limited - Expected earnings per share growth for next year|Expected earnings per share trend next year ATYR|Adagene Corp - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year ImageneBio Inc IMA|shattucklabs.com (STTK) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Equillium|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Expected earnings per share growth for next year Immunic Inc (IMUX)|Expected earnings per share growth for next year ATRA (Atara Biotherapeutics)|Earnings growth forecast for next year inflarx.de (IFRX)|Net earnings per share growth forecast for next year X4 Pharma XFOR|ACET: Projected earnings per share growth rate for next year|Celularity Corp - Earnings growth forecast for next year|Expected net earnings per share growth next year inmunebio.com|BRNS: Earnings growth forecast for next year|KZR - Consensus forecast of earnings per share growth for next year|SABS (SAB Biotherapeutics, Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year AKTX|Earnings growth forecast for next year ENLV|Consensus forecast of earnings per share growth for next year q32bio.com|Net earnings per share growth forecast for next year GeoVax GOVX|Edesa Biotech Inc (EDSA) - Expected net earnings per share growth next year|CARM: Expected earnings per share growth for next year|Expected earnings per share trend next year XTLB (XTL Bio)|BOLT: Earnings growth forecast for next year|HCWB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Projected earnings per share growth rate for next year AIM (AIM ImmunoTech, Inc.)|Earnings growth forecast for next year ADTX|Expected earnings per share growth for next year GRI Bio Corporation GRI|XORTX Therapeutics Inc. - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year reshapelifesciences.com (HIND)|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Indaptus Therapeutics Inc INDP|SCNI: Earnings growth forecast for next year|CALI (CalciMedica) - Net earnings per share growth forecast for next year|AFMD (Affimed NV) - Earnings growth forecast for next year|Allakos Therapeutics (ALLK) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGMS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year iTeos ITOS|OCEA (Ocean Biomedical Corp) - Net earnings per share change forecast for next year|TC Biopharm - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (thirdharmonicbio.com)
